Skip to main content
PTGX $127.16 +2.00%
PTGX logo
PTGX · Protagonist Therapeutics, Inc
Track PTGX — free
$127.16 +2.49 (+2.00%) At close · Nov 18 Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18 433.18K Avg daily vol (3M) 666.83K
All webcasts

Earnings call · FY2024 Q4

Protagonist Therapeutics, Inc (PTGX) Q4 2024 Earnings Call

Concluded Feb 21, 2025
Feb 21, 2025
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $170.64M +184.4% YoY
Net income · derived Q4 $131.67M +381.7% YoY
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document